Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | KDM1A | O60341 | 3/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 4/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.44 |
| ▸ | P2RX1 | P51575 | 3/20 | 0.43 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 4/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | TMPRSS4 | Q9NRS4 | 3/20 | 0.42 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.42 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 4/20 | 0.42 |
| ▸ | ALOX12 | P18054 | 3/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27858173 | 1.00 | CA1 (0.52) | CA1CA2KDM1AHSD17B10TSHR | |
| SCHEMBL19142589 | 0.84 | MEN1 (0.63) | CA1CA2KDM1AHSD17B10TSHR | |
| SCHEMBL22319627 | 0.82 | KDM1A (0.50) | CA1CA2KDM1AHSD17B10TSHR | |
| SCHEMBL20598000 | 0.82 | KDM1A (0.50) | CA1CA2KDM1AHSD17B10TSHR | |
| SCHEMBL17089325 | 0.75 | CA1 (0.55) | CA1CA2KDM1AHSD17B10TSHR | |
| SCHEMBL14364717 | 0.75 | CA1 (0.55) | CA1CA2KDM1AHSD17B10TSHR | |
| SCHEMBL218964 | 0.75 | CA1 (0.67) | CA1CA2KDM1AHSD17B10MEN1 | |
| Hydrochloric Acid SCHEMBL11784623 | 0.73 | CA1 (0.64) | CA1CA2KDM1AHSD17B10MEN1 | |
| Bromide SCHEMBL30207997 | 0.73 | CA1 (0.64) | CA1CA2KDM1AHSD17B10MEN1 | |
| SCHEMBL26875164 | 0.73 | CA1 (0.53) | CA1CA2HSD17B10TSHRMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220087957-A1 | Targeting mitochondrial dynamics by mitochondrial fusion promoter M1 as a treatment strategy for nervous system injury | CITY UNIVERSITY OF HONG KONG (CN) | 2022-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220087957-A1 | Targeting mitochondrial dynamics by mitochondrial fusion promoter M1 as a treatment strategy for nervous system injury | MFN2, NLN, TFAM | CA1 1721/4885CA2 2782/4885KDM1A 1594/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.